Seeking Alpha

Oppenheimer initiates its coverage on Mako Surgical (MAKO +1.1%) with a tepid Neutral rating on...

Oppenheimer initiates its coverage on Mako Surgical (MAKO +1.1%) with a tepid Neutral rating on its view that the current valuation on the stock already factors in the buzz over its results with its partial-knee replacement product and the rollout of a new application. Shares +66.1% YTD.
Comments (1)
  • labas112
    , contributor
    Comments (321) | Send Message
     
    Ticker is wrong needs to be MAKO
    13 Apr 2012, 10:13 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector